M. Lerner

发表

P. Hochman, T. Plavina, M. Lerner, 2010 .

Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M3 chimeric G protein-coupled receptor.

G. Milligan, F. Zeng, D. Behan, 2003, Molecular pharmacology.

Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma.

K. Simon, L. Gorelik, M. Subramanyam, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders

Robert M. Jones, D. Buzard, J. Edwards, 2008 .

Anti‐JC virus antibodies: Implications for PML Risk Stratification

K. Simon, A. Sandrock, S. Bixler, 2010, Annals of neurology.

Purinergic signaling modulates human visceral adipose inflammatory responses: implications in metabolically unhealthy obesity

L. Fainboim, J. Pandolfi, L. Arruvito, 2015, Journal of leukocyte biology.

PEGylated interferon beta-1a: meeting an unmet medical need in the treatment of relapsing multiple sclerosis.

I. Nestorov, D. Baker, M. Panzara, 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Anti‐JC virus antibodies: Implications for PML Risk Stratification

K. Simon, A. Sandrock, S. Bixler, 2010, Annals of neurology.

Risk factors of laryngeal cryptococcosis: A case report

L. Pirofski, Polina Trachuk, Judy Sarungbam, 2019, Medical mycology case reports.